Johnson & Johnson CEO – Alex Gorsky (Age – 65)

FORMER CEO: Alex Gorsky served as Chairman & CEO of Johnson & Johnson from 2012 to 2022. He transitioned to Executive Chairman in January 2022 and retired in January 2023. The current Chairman & CEO of Johnson & Johnson is Joaquin Duato, who assumed the role in January 2022.

Johnson & Johnson, one of the world’s largest and most diversified healthcare companies, was led by Alex Gorsky as Chairman and Chief Executive Officer from 2012 to 2022. A decorated U.S. Army veteran and West Point graduate, Gorsky spent the majority of his career at Johnson & Johnson, rising from a sales representative at Janssen Pharmaceutica in 1988 to the top leadership position. Under his decade-long tenure, J&J grew from roughly $67 billion to over $93 billion in annual revenue, navigated complex challenges including the opioid litigation crisis and the COVID-19 pandemic, and developed one of the world’s first single-dose COVID-19 vaccines. Today, Gorsky remains influential as a board director at Apple, IBM, and JPMorgan Chase, and as a General Partner at ICONIQ Capital.

Read on to learn about former Johnson & Johnson CEO Alex Gorsky’s net worth in 2026, his salary and compensation history, career timeline, wife & family, education, email address, and more.
Alex Gorsky Johnson and Johnson CEO
Alex Gorsky, Former Chairman & CEO of Johnson & Johnson • Photo: Johnson & Johnson

Alex Gorsky – Quick Facts

Alex Gorsky — At a Glance
Full Name Alex Gorsky
Position (Former) Chairman & Chief Executive Officer (2012–2022)
Company Johnson & Johnson (NYSE: JNJ)
Age 65 years (born May 24, 1960)
Education B.S. U.S. Military Academy at West Point; MBA, The Wharton School, UPenn
Net Worth (Est. 2026) $200–240 Million
Last CEO Compensation ~$26.7 Million (FY2021)
CEO Tenure April 2012 – January 2022
Current Roles Board Director: Apple, IBM (Lead Director), JPMorgan Chase; GP, ICONIQ Capital
Email [email protected]
LinkedIn linkedin.com/in/alex-gorsky

Johnson & Johnson Competitors

Johnson & Johnson competes across multiple healthcare sectors including pharmaceuticals, medical devices, and consumer health. The key competitors of Johnson & Johnson include:

  • Pfizer – global pharmaceutical giant competing in vaccines, oncology, and immunology
  • AbbVie – major biopharmaceutical company (Humira, Skyrizi, Rinvoq)
  • Roche – Swiss pharma and diagnostics leader (Genentech subsidiary)
  • Eli Lilly – global pharma with leading diabetes and oncology portfolios
  • Merck & Co. – pharma competitor in oncology (Keytruda) and vaccines
  • Novartis – Swiss pharmaceutical multinational across multiple therapeutic areas
  • AstraZeneca – biopharmaceutical company in oncology, cardiovascular, and respiratory
  • Medtronic – global leader in medical devices and technologies

Alex Gorsky Net Worth 2026 – Johnson & Johnson CEO Salary

As of 2026, Alex Gorsky’s net worth is estimated at approximately $200–240 million USD. This estimate reflects his extensive stock holdings accumulated over a decade as CEO, plus board compensation from Apple, IBM, and JPMorgan Chase, and his role as General Partner at ICONIQ Capital. During his tenure, Gorsky earned over $162 million in total disclosed compensation from Johnson & Johnson alone.

Alex Gorsky – J&J CEO Compensation Breakdown (FY2021, Final Full Year as CEO)

Component Amount (USD) Share
Base Salary $1,650,000 6.2%
Non-Equity Incentive Plan $4,300,000 16.1%
Stock Awards $15,000,000 56.1%
Option Awards $5,100,000 19.1%
Other Compensation $691,959 2.6%
TOTAL $26,741,959 100%
Key Insight: Over 93.8% of Alex Gorsky’s final-year compensation was performance-based (bonus + equity + options), with only 6.2% from base salary. His base salary of $1.65 million had remained unchanged since 2019. Over his full 10-year tenure as CEO, Gorsky earned more than $162 million in total disclosed compensation.

Johnson & Johnson Net Worth 2026 – Is J&J Profitable?

Yes, Johnson & Johnson is one of the most profitable companies in the world. Under current CEO Joaquin Duato, the company has continued the growth trajectory built during Alex Gorsky’s tenure, reaching nearly $94.2 billion in revenue for full-year 2025 and a market capitalization approaching $600 billion.

Johnson & Johnson Financial Summary (FY2025)

Metric Value YoY Change
Market Capitalization ~$599B ▲ 60%
Annual Revenue $94.2B ▲ 6.0%
Net Income $26.8B ▲ 90.6%
Earnings Per Share $11.03 ▲ Strong
Adjusted EPS $10.79 ▲ Growing
Employees 130,000+
Dividend Yield ~2.1%
NYSE Ticker JNJ
J&J Under Gorsky’s Legacy: When Alex Gorsky became CEO in 2012, J&J had annual revenue of approximately $67 billion. By his departure in 2022, revenue had grown to over $93 billion. The company now has a market capitalization approaching $600 billion, making it one of the most valuable healthcare companies on Earth.

Alex Gorsky Contact – Email Address & Social Media

Below are the available contact details and social media profiles for former Johnson & Johnson CEO Alex Gorsky:

Contact Information
Email Address [email protected]
LinkedIn linkedin.com/in/alex-gorsky
Corporate HQ (J&J) One Johnson & Johnson Plaza, New Brunswick, NJ 08933
Current Affiliation General Partner, ICONIQ Capital
Board Memberships Apple Inc., IBM (Lead Director), JPMorgan Chase

Career & Education – Company, University, & College

Alex Gorsky’s career spans over three decades in the pharmaceutical and healthcare industry, combined with distinguished military service. He is one of the longest-serving CEOs in Johnson & Johnson’s modern history, leading the company for a full decade. Below is his complete career timeline:

Alex Gorsky Career Timeline

Period Role Company
1982–1988 U.S. Army Officer (Captain, Army Ranger) United States Army
1988–2001 Sales Representative → Various Leadership Roles Janssen Pharmaceutica (J&J)
2001–2003 President, Janssen Pharmaceutica Johnson & Johnson
2003–2004 Company Group Chairman, Pharma (EMEA) Johnson & Johnson
2004–2008 COO & Head of Pharma North America / CEO Novartis Pharmaceuticals
2008–2009 Company Group Chairman, Ethicon Johnson & Johnson
2009–2011 Worldwide Chairman, Surgical Care Group & Executive Committee Member Johnson & Johnson
2011–2012 Vice Chairman, Executive Committee Johnson & Johnson
2012–2022 Chairman & Chief Executive Officer Johnson & Johnson
2022–2023 Executive Chairman Johnson & Johnson
2023–Present General Partner; Board Director (Apple, IBM, JPMorgan Chase) ICONIQ Capital & Boards

Alex Gorsky began his Johnson & Johnson career as a sales representative with Janssen Pharmaceutica in 1988, shortly after completing his military service. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing, and management across J&J’s pharmaceutical businesses. In 2001, he was appointed President of Janssen, and in 2003, he was promoted to Company Group Chairman for J&J’s pharmaceutical business in Europe, the Middle East, and Africa.

In 2004, Gorsky departed to join Novartis Pharmaceuticals Corporation as Chief Operating Officer and Head of General Medicines. He subsequently became Head of Pharma North America and CEO of Novartis Pharmaceuticals. However, in 2008, Gorsky returned to Johnson & Johnson as Company Group Chairman for Ethicon, the company’s surgical care division.

By 2009, he was appointed Worldwide Chairman of the Surgical Care Group and a member of the Executive Committee. In 2011, he became Vice Chairman of the Executive Committee, and in April 2012, he was named CEO of Johnson & Johnson, succeeding William C. Weldon. He added the Chairman title in December 2012. In January 2022, Gorsky transitioned to Executive Chairman, handing the CEO role to Joaquin Duato, and retired fully from J&J in January 2023.

Education

University Degree / Program Website
U.S. Military Academy at West Point Bachelor of Science (1982) westpoint.edu
The Wharton School, University of Pennsylvania Master of Business Administration (1996) wharton.upenn.edu
U.S. Military Academy at West Point campus
United States Military Academy at West Point, New York — where Alex Gorsky earned his Bachelor of Science degree in 1982. Photo: Wikimedia Commons (Public Domain)

Alex Gorsky Wiki – Age, Wife, Family, & More

Alex Gorsky (age 65, born May 24, 1960) grew up in a close-knit family with his parents Albert and Loretta Gorsky and five siblings. After graduating from West Point in 1982, he served six years in the U.S. Army as an Army Ranger, achieving the rank of Captain before transitioning to the private sector.

In 1988, Gorsky married Patricia (Pat) Dittrich, a hospital nurse in Carmel, California. The couple have one son, Nick. Gorsky has long credited his wife and sister Therese, both nurses, as major influences in his understanding of the healthcare system. He and Pat have been generous philanthropists, donating $5 million to the Doylestown Health Foundation in 2017 and another $5 million in 2022.

Notable Achievements & Recognitions

  • COVID-19 Vaccine Development – Led J&J’s development of the single-dose Janssen COVID-19 vaccine, one of the first authorized worldwide
  • PharmaVoice “100 Most Inspiring Leaders” – Named in 2017 for his industry leadership
  • Barron’s Most Admired Company – Under his leadership, J&J was ranked as the world’s most admired company (2016)
  • Board Director at Apple, IBM, and JPMorgan Chase – Serves on three of the world’s most influential corporate boards
  • IBM Lead Independent Director – Has served on IBM’s Board since 2014
  • Veterans’ Advocate – Long-standing champion of veterans’ employment and inclusion initiatives
  • Travis Manion Foundation Board Member – Supports veterans and families of fallen heroes
  • Wharton School Board of Advisors – Active advisor at his MBA alma mater

Gorsky has long advocated for work-life balance and diversity in the workplace. He is known for saying that one of the most important lessons he learned early in life was to “be pleased but not satisfied” — a philosophy that drove his decade-long leadership of one of the world’s largest healthcare companies.

About Johnson & Johnson

Johnson & Johnson is an American multinational healthcare corporation headquartered in New Brunswick, New Jersey. Founded in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson, the company is one of the oldest and most diversified healthcare enterprises in the world. Following the 2023 spin-off of its consumer health division as Kenvue, Johnson & Johnson now operates in two primary segments:

Segment Key Areas Description
Innovative Medicine Oncology, Immunology, Neuroscience, Cardiovascular Prescription pharmaceuticals including Darzalex, Stelara, Tremfya, and Erleada
MedTech Surgery, Vision, Orthopedics, Interventional Solutions Medical devices, surgical instruments, contact lenses, and robotics-assisted surgery

Johnson & Johnson trades on the New York Stock Exchange under the ticker symbol JNJ. With a market capitalization of approximately $599 billion as of early 2026, it is one of the most valuable healthcare companies in the world. The company employs over 130,000 people globally and has been a constituent of the Dow Jones Industrial Average since 1997.

Frequently Asked Questions (FAQ)

Who is the current CEO of Johnson & Johnson?

The current Chairman and CEO of Johnson & Johnson is Joaquin Duato, who assumed the CEO role in January 2022. Alex Gorsky served as Chairman & CEO from 2012 to 2022 before transitioning to Executive Chairman and then retiring in January 2023.

What is Alex Gorsky’s net worth in 2026?

As of 2026, Alex Gorsky’s net worth is estimated at approximately $200–240 million USD. This estimate is based on his accumulated J&J stock holdings from over a decade as CEO (he earned $162+ million in total disclosed compensation), combined with board fees from Apple, IBM, and JPMorgan Chase, and his investment role at ICONIQ Capital.

What was Alex Gorsky’s salary as J&J CEO?

Alex Gorsky’s total compensation for his final full year as CEO (fiscal year 2021) was approximately $26.7 million, including a $1.65 million base salary, $4.3 million annual bonus, $15 million in stock awards, and $5.1 million in option awards. Over 93% of his pay was performance-based.

What is Alex Gorsky’s email address?

Alex Gorsky’s email address at Johnson & Johnson was [email protected]. He can also be reached via his LinkedIn profile. For general J&J inquiries, contact the corporate headquarters at One Johnson & Johnson Plaza, New Brunswick, NJ 08933.

What does Alex Gorsky do now?

Since retiring from Johnson & Johnson in January 2023, Alex Gorsky has remained active in the corporate world. He serves as a General Partner at ICONIQ Capital, a technology-focused investment firm. He also sits on the boards of Apple Inc., IBM (as Lead Independent Director), JPMorgan Chase, and Xaira Therapeutics. He continues his philanthropic work through the Travis Manion Foundation and the Wharton School Board of Advisors.

Is Johnson & Johnson a profitable company?

Yes, Johnson & Johnson is highly profitable. In fiscal year 2025, the company reported revenue of $94.2 billion (up 6.0% year-over-year) and net income of $26.8 billion (up over 90% year-over-year). With a market capitalization approaching $600 billion and a consistent dividend history spanning over 60 years, J&J remains one of the most financially robust companies in the world.

Article last updated:February 2026March 2, 2026

Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, and reputable news outlets. This content is provided for informational purposes only and does not constitute financial or investment advice. Net worth figures are estimates and may vary by source.

Last updated: March 2026